The Deadly Spike By Brian Simpson

A concise summary of the dangers that the mRNA spike proteins pose to the human body has been given by Tabletmag.com, which always has good reading, with no paywall so plebs like me can sample the richness. The fact is that despite the propaganda put out by our health authorities, the mRNA spike protein, from either the infection via the virus, or from the vax, is toxic, killing or damaging human cells. Evidence has accumulated from tissue samples from people who have been vaxxed and died, through autopsies. In fact, there has been a build-up of peer-reviewed articles documenting the damages done by this protein. The mRNA spike protein reaches every organ in the body, including the brain and ovaries, and particularly the heart. What follows is a printable summary of these harms, a one-stop shop of horror, so to speak.

https://www.tabletmag.com/sections/science/articles/the-spike

“Here are some of the things that the spike protein has been found to have the potential to do. In the cardiovascular system: One segment of spike can signal the cells of blood vessels in the lungs to grow, causing “thickened” vessel walls typical of pulmonary hypertension, a condition that makes it harder for the heart to pump blood into the lungs; that same fragment, S1, can damage the cells which line the inside of every blood vessel in the body including the lungs; can damage the cells in your heart which work in concert with those cells; can cause the heart to become fibrotic; and can, says this 2022 paper, even contribute to the development of myocarditis, an inflammatory condition of the heart muscle which weakens it, and can cause sudden death in recovered patients. The Cleveland Clinic estimates that the survival rate for myocarditis is 80% after one year and 50% after five.

In the blood: Spike can deform our clotting cells—or platelets—sometimes irreversibly activating them; it binds to blood clotting proteins and creates clots that are “structurally abnormal”; it can cause microclots from red blood cells clumping together that deplete blood oxygen levels. David Scheim, an independent researcher who co-authored a study published in December 2022 about those microclots with a team from France’s famed Méditerranée Infection Institute in Marseille, told Tablet that their experiment revealed the red blood cell clumping “is actually visible [to the naked eye], it forms a film so you don’t even need a microscope, you just add the spike to a suspension of red blood cells and you see this clumping.”

In the brain: The S1 fragment of spike has been shown to move straight across the blood brain barrier, the all-important gatekeeper of the brain, in humanized mice. Once it’s in, the spike can damage cells that line the walls of blood vessels in the brain, lead to memory loss, or disrupt the mitochondria of similar brain blood vessel cells, potentially triggering “a more severe form of stroke.” Perhaps more ominously, certain sequences on the S1 portion of the spike are able to bind to amyloid proteins that have been known to cause severe neurological disease. The proteins that spike is able to bind are related to the development of Alzheimer’s, Parkinson’s, and Creutzfeldt-Jacob, an irreversible, and fatal brain disease. Additionally, the spike itself may be considered an amyloid, a misfolded protein that can grow and form fibrous plaques. Think of the 1958 horror classic The Blob, but at a cellular level.

In short, spike can contribute to cardiovascular damage, brain damage, blood clots, autoimmunity, cell deformation, and cell-to-cell fusion. As Walter Chesnut, an independent researcher, has previously written, “It is a Swiss Army Knife of death.” Chesnut co-authored an article in 2021 with a group of scientists, doctors, and journalists that included Luc Montagnier (who won a Nobel Prize for his discovery of HIV) outlining what may tie together all of the spike’s nasty effects. They theorized that spike preys on our DNA, and that repeated exposure will prematurely age us, leading to earlier death by natural causes. “Spike is spike. The more the worse,” Chesnut told Tablet.

The Chesnut and Montagnier et al. hypothesis that spike protein can accelerate biological aging is still novel, and not widely accepted. Professor Masfique Mehedi, a microbiologist and virologist who has studied Ebola at the prestigious Rocky Mountain Laboratories, and whose work shows that COVID spike can enter the nucleus of our cells, told Tablet that their hypothesis may be “premature.” There is, however, mounting evidence that the larger idea that vaccine-induced spike could be harming people is worth taking seriously.

The spike protein of SARS-CoV-2 is not precisely identical to the spike used in the vaccines, though they are very similar. First of all, at any given point in time, the wild-type spike is mutating (e.g., omicron) with unknown consequences, whereas the vaccine spikes are predetermined. But the design of the vaccine spike was deliberately altered from the original in at least two key ways: to increase stability, and to “lock” the protein in its “prefusion” shape, in the hopes that it would teach our immune system to recognize and neutralize the virus’s spike before it has a chance to bind to our cells.

One argument against the spike protein hypothesis of vaccine injury—meaning the notion that exposure to the spike protein is the main cause of the vaccine’s potentially severe side effects—is that due to the changes locking the spike in its prefusion shape, it can’t cause the damage alleged. However, many of the examples provided above of spike-related pathologies don’t require cell-binding, but rather just require exposure.

Because of how dangerous it is, some believe that it’s a secondary question where the spike is coming from, COVID or the treatments for COVID—all that really matters is that it’s coming into contact with your cells. “The more spike, the greater the risk. So if you have COVID and get vaccinated, you have a greater risk, if you are vaccinated and you get COVID, you have a greater risk,” Marik said. In February 2023, a group of researchers from the University of Colorado seemed to affirm Marik’s contention. After assessing a small group of patients with myocarditis, they concluded: “These observations suggest that myocardial injury during COVID-19 or after mRNA vaccination may be produced by the same Spike protein–based mechanism, which may be amenable to preventative or therapeutic strategies.”

A second argument against the hypothesis is that there simply isn’t enough spike released into the blood after vaccination to cause the kinds of issues we’ve seen in COVID patients. “The low doses of the spike protein in the vaccine, in our experiments anyway, didn’t cause any recognizable damage,” Dr. Nuovo told Tablet. Nonetheless, Nuovo abstained from getting his third vaccine dose because “the initial vaccine data showed that people who didn’t get the booster were still very well protected against severe COVID, and the second point was I didn’t see the point of introducing more spike protein into my body if there was no benefit to be coming from it … because the spike protein per se does have some toxicity associated with it.”

There is another way that the vaccines might be causing harm. Due to FOIA requests from Judicial Watch and others, we now know that the vaccine material travels beyond the upper arm muscle throughout the body, in spite of the CDC’s web page maintaining the 2020 narrative that it stays put. Because the vaccines were designed to express the full-length spike protein in our cells, some researchers like professor Mehedi worry that the vaccines could be inducing a major attack of the immune system against healthy cells throughout the body. “An unfortunate & unimaginable detrimental consequence … face[d] by everyone who took it due to a poor and unacceptable design by the low-grade researchers and opportunistic makers.”

That kind of candor is hard to come by when the price for expressing an idea or trying to test a theory can be the destruction of one’s career and social life, as happened to numerous researchers and scientists, including Marik. For his views on COVID treatment in the ICU, like not wanting to use the highly toxic antiviral drug remdesivir, and probably for his stated viewpoint on the spike protein and vaccines, Marik was suspended from his role as ICU director of Sentara General Hospital in Norfolk, Virginia, in late 2021. He resigned from his role as professor at East Virginia Medical School shortly after. Marik says his colleagues no longer talk to him. “Not a single one.”

Yet, the data has a way of piling up, even if many in science, media, and government have avoided acknowledging its implications: By October of last year there had been at least 1,250 studies published in medical journals documenting events as disparate as Bell’s palsy, multiple sclerosis, central venous thrombosis, encephalitis, inflammatory bowel disease, myocarditis, etc. after vaccination. For one awful example, take this recent case report from Tokushima University in Japan documenting the “fatal multi organ inflammation” of a 14-year-old girl after her booster. Then there are the adverse event-monitoring systems, the joint-run CDC/FDA VAERS (Vaccine Adverse Event Reporting System) being the most notable. As of March 31, 2023, there have been over 1.5 million adverse events reported in the system, with nearly 200,000 involving hospitalization. While VAERS is a very imperfect system, with some critics claiming massive underreporting and others, overreporting, there is a clear signal that injuries are occurring. German Health Minister Karl Lauterbach said in a March 2023 interview that the rate of “serious vaccination damage” may be as high as 1 in 10,000.

Defining the ultimate numbers of how many people are being affected by various side effects is a difficult task, but looking at the original trial data does give some context. Last September, a team of researchers, including two from UCLA, one from Stanford, and one editor of the British Medical Journal, published a study in Vaccine titled, “Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults,” which reviewed the Pfizer and Moderna trial data. While the investigators note that their study was hampered by their lack of access to the raw data, which the companies have not made available, they concluded that, “The excess risk of serious adverse events found in our study points to the need for formal harm-benefit analyses, particularly those that are stratified according to risk of serious COVID-19 outcomes.”